Monoclonal Antibodies an Option for Oncohematology Patients Monoclonal Antibodies an Option for Oncohematology Patients

Monoclonal antibodies are the best option against SARS-CoV-2 for oncohematology patients, although viral variants may reduce the efficacy of these treatments.Medscape Medical News
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Hematology-Oncology News Source Type: news